title: Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?
authors.affiliation: Department of Cardiovascular Science, University of Sheffield, Sheffield, UK; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital Sheffield, UK.
authors.forename: M
authors.initials: M
authors.lastname: Makris
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D004338:Drug Combinations; D005164:Factor IX / Q000008:administration & dosage*; D005167:Factor VII / Q000008:administration & dosage*; D005170:Factor X / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage*; D011516:Prothrombin / Q000008:administration & dosage*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D001779:Blood Coagulation Factors; D004338:Drug Combinations; D009025:Morpholines; D013876:Thiophenes; C025667:prothrombin complex concentrates; D005167:Factor VII; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X; D000069552:Rivaroxaban; C000599051:Profilnine SD